Follow the 3B BlackBio Dx stock price and the full management transaction log of the company, a listed equity based in India. Shares are listed on the IN market, under the authority of SEBI (PIT + SAST). Market capitalisation: €11.9bn. The latest transaction was reported on 14 July 2026 (Acquisition). Among the most active insiders: Dhirendra Dubey. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
3B BlackBio Dx is a company focused on developing innovative diagnostic solutions. It operates in the XBOM market.